Nektar Therapeutics · NASDAQ:NKTR
BlackRock, Inc.'s stake in Nektar Therapeutics fell to 1.60% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 18, 2025
BlackRock, Inc.'s stake in Nektar Therapeutics fell to 1.60%, 203,017 shares, as a passive investor on Jun 30, 2025. Filed Jul 18, 2025 (Schedule 13G/A).
- Stake
- 1.60%
- Shares
- 203,017
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.60% | 203,017 |
Source
Related
- Nektar Therapeutics
- BlackRock, Inc.
- Nektar Therapeutics shareholders
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026